• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameARCHITECT AUSAB, ARCHITECT I1000 SYSTEM
Classification Nametest, hepatitis b (b core, be antigen, be antibody, b core igm)
ApplicantABBOTT LABORATORIES INC
PMA NumberP050051
Supplement NumberS004
Date Received02/12/2009
Decision Date07/23/2009
Product Code
LOM[ Registered Establishments with LOM ]
Advisory Committee Microbiology
Supplement Typenormal 180 day track
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval to extend the application of the architect ausab assay, currently approved for use on the abbott architect i2000/ i 2000sr, onto a new architect i system family member, the architect i 1000sr. Architect ausab reagent kit on architect i 1000sr: the architect ausab assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in human adult and pediatric serum and plasma (dipotassium edta, lithium heparin, and sodium heparin) and neonatal serum. It is intended for quantitative measurement of antibody response following hepatitis b virus (hbv) vaccination, determination of hbv immune status, and for the laboratory diagnosis of hbv disease associated with hbv infection when used in conjunction with other laboratory results and clinical information. Architect ausab calibrators on architect i 1000sr: the architect ausab calibrators are used to calibrate the architect i system when the system is used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab calibrators has not been established with any other anti-hbs assay. Architect ausab controls on architect i 1000sr: the architect ausab controls are used for monitoring the performance of the architect i system when used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab controls has not been established with any other anti-hbs assay.
-
-